Table 1. Genotypes associated with increased disease-free survival in sunitinib versus placebo groups.

Genotype	HR	95% CI	P
VEGFR1 rs9554320 C/C	0.44	0.21–0.91	0.023
VEGFR2 rs2071559 T/T	0.46	0.23–0.90	0.020
eNOS rs2070744 T/T	0.53	0.30–0.94	0.028
†VEGFR1 rs9582036 A/A	0.56	0.30–1.02	0.054

^†, approached statistical significance. HR, hazard ratio; CI, confidence interval.